Junin virus causes Argentine hemorrhagic fever (AHF), an acute severe disease with a human mortality rate of ca. 15%. When infected with human pathogenic viral isolates, guinea pigs manifest a disease similar to that expressed in humans; lethal disease in guinea pigs is a widely used virulence marker for Junin strains (6, 8) .
AHF in humans and guinea pigs possesses certain similarities to the well-studied murine model infection with another member of the family Arenaviridae, lymphocytic choriomeningitis virus (LCMV). Both viruses replicate to high titer in reticuloendothelial organs, are immunosuppressive, and cause transient hematopoietic dysfunction (4, 7, 24) . In mice inoculated intracranially with LCMV, the onset of acute disease has been definitively linked to damage caused by the host immune response to the virus, specifically by virus-specific T-lymphocytes (13) . Mice infected with Junin and other arenaviruses often develop a histologically similar encephalitis which is ameliorated in congenitally athymic, neonatally thymectomized, or immunosuppressed hosts (2, 9, 31). These findings have led to speculation that immunopathological mechanisms may underlie disease induction in human AHF. Since guinea pigs are classically used as a model for human AHF, we examined the effects of immunosuppression on these animals infected with virulent or attenuated Junin strains to elucidate the role of an immune response in precipitating the hemorrhagic fever syndrome. For immunosuppression we used cyclophosphamide (CY), a global irhmunosuppressant (25, 27) , and cyclosporin A (C-A), an endecapeptide selective for T-cells (3, 10, 19) .
MATERIALS AND METHODS Animals. Hartley strain, male guinea pigs (weight, 300 to 400 g) ( (28) . Guinea pigs were inoculated with virus by intraperitoneal injection. On preselected days, organs were removed from animals; samples were weighed, suspended in L-15 buffer, processed in tissue culture grinders, and assayed for virus. To test for replication of virulent mutants or for a virulent subpopulation in immunosuppressed, XJ-44-infected guinea pigs, a spleen cell homogenate was prepared from a moribund, XJ-44-infected, CY-immunosuppressed guinea pig; 105 PFU of virus was inoculated intraperitoneally into both untreated and immunosuppressed guinea pigs. This procedure was used for three sequential spleen cell homogenate passages.
Immunosuppression. A single dose (250 mg/kg) of CY (Cytoxan; Mead Johnson and Co., Evansville, Ind.) was administered to guinea pigs intraperitoneally 3 days before inoculation with virus. This single large dose given 3 days before virus infection resembles that used by Turk and Parker (27) cell-grown virus from each of the three passages failed to cause illness or death when inoculated into normal guinea pigs.
To confirm the immunosuppressive effects of drug treatment in XJ-44-infected guinea pigs, anti-Junin antibody production was examined (Fig. 1) . In XJ-44-infected, nonimmunosuppressed animals, significant antibody was present by day 13, as measured by IFA assay, and by day 21, as measured by PRN assay. However, when animals were immunosuppressed with either CY or C-A, PRN antibody failed to develop, and fluorescent antibody was undetectable or was detected at very reduced levels.
In XJ-44-infected guinea pigs, the effect of immunosuppression on cytotoxicity of spleen cells for Junin virus-infected target cells is shown in Fig. 2 . Spleen cells from infected untreated guinea pigs effected up to 40% 51Cr release. However, spleen cells from infected, immunosuppressed guinea pigs demonstrated nearly the same cytotoxicity (CY animals) as or only slightly more cytotoxicity (C-A animals) than spleen cells from normal uninfected guinea pigs. Responses at days 12 and 16 were similar. Later time points were not measured due to the increasing severity of the disease.
Virus titers in samples from Romero-infected animals ( Fig. 3A) resembled those previously reported with the virulent Junin XJ strain (5) . Infectivity was first apparent in spleen and lymph nodes by day 5, reaching levels of 5.5 to 6.5 log1o PFU/g in these organs and bone marrow. Virenlia was first detected on day 7 and reached levels in excess of 4 log10 PFU/ml by day 11. High virus titers persisted until death, around day 15. In contrast, XJ-44 virus was detected for only a brief time span (days 5 through 7), in limited distribution (lymph nodes and spleen) and in low titer (less than 3.5 log10 PFU/g) (Fig 3B) .
CY-immunosuppressed guinea pigs infected with XJ-44 had detectable organ virus titers by days 5 to 7, rising to°, (Fig. 3C) . Viremia was detected at low levels on days 7 to 16. C-A-treated animals had similar XJ-44 titers, except at later time points when organ virus titers were even higher (5.1 to 6.4 log10 PFU/g), and there was clear evidence for brain invasion (Fig. 3D) . Brain virus exceeded 4.0 log10 PFU/g in the absence of detectable viremia in most animals examined after day 20 and was often associated with clinical findings of hind-limb paralysis.
Histopathological lesions in samples from Romero-infected animals (Table 2 ) also resembled those previously reported with the Junin XJ strain (5, 7) . The primary lesions consisted of necrosis of bone marrow, lymphoid depletion of lymph nodes and spleen, and, terminally in some cases, lymphoid necrosis of the spleen. Lesions increased in severity as the disease progressed. Although sparse antigen was detected in brain tissue (cortex) by day 11, no significant lesions were observed in either medulla or cortex, even in moribund animals at day 15. In contrast, samples from guinea pigs infected with XJ-44 virus demonstrated very limited viral antigen on days 8 and 14 in bone marrow, lymph nodes, and spleen. Minimal lesions consisting of lymphoid depletion were found in lymph nodes and spleen, but no lesions were observed in bone marrow. Occasionally, nonsuppurative, multifocal encephalitis and gliosis were observed in the medulla, but viral antigen was not observed in the brain by fluorescence, although the medulla was not included in the brain section examined by this technique. When observed in any organ by IFA assay, viral antigen was randomly distributed and not confined to a single cell type.
CY-immunosuppressed guinea pigs infected with XJ-44 had detectable viral antigen in spleen, bone marrow, and (15) . LCMV inoculated intracranially in the adult mouse is the classical model and probably shares similar pathogenesis with LCMV-induced aseptic meningitis in humans (22) . Junin virus in mice and rats also appears to induce an immunopathological encephalitis after intracranial inoculation (17, 18) . However, viral hemmorhagic fevers in humans to not present this pattern; in particular, cellular infiltrates are scant, and virus titers do not necessarily decline with the onset of disease (22a) . Realistic models for these hemorrhagic fevers have been developed in nonhuman primates and guinea pigs (22) , but the effects of immunosuppression have not been carefully studied. We examined the effects of two potent immunosuppressive drugs on infection with a low-passage guinea pig-virulent human isolate (Romero strain ). In contrast to the established action of CY in ameliorating immunopathological encephalitis in mice and rats, there was no effect in the guinea pig viral AHF model. Animals died in the same time after inoculation and with similar histopathological lesions as unmanipulated infected +1  0  14  +1  0  +1  +2  +1  +2  17  0  0  0  +1  0  +1  28  0  0  0  0  0  +1   XJ-44 (C-A)  14  +1  0  +3  +2e  +2  +2  18  +1  +3  +2  21   -0  +3  +2  +2   +2  23  +3  +3  0  +2  25  +3  +3  +3  +2  +3  +2 XJ-44 (CY) +2  12  +1  +1  +2  0  +2  0  18  +2  +2  +2  +2  0  24  +1  +3  +2  +3  +2   Romero  5  +1  0  +1  7  +1  +1  0  9  +1  -+1  +1  11  +3  +1  -+2  13  +3  -0  +3  15 +3 +2 +2 a Both brain cortex and medulla were examined for lesions; only cortex was examined for antigen. Significant lesions were not consistently observed in either cortex or medulla of any of the experimental animals. Antigen was observed only in immunosuppressed, XJ-44-infected animals and in Romero-infected animals and was a late event usually involving only a few cells. controls. We also studied the effects of immunosuppression on infections with Junin strain (XJ-44) attenuated for rhesus monkeys and guinea pigs (J. Barrera Oro and R. H. Kenyon, unpublished data). This virus in unmodified adult outbred guinea pigs kills <1% and usually results in mild encephalitis or late "no-lesion" disease, never florid hemorrhagic fever. The virus resembles its cousin XJ-clone 3 in quantitative virulence titrations in immature guinea pigs and mice. However, we found that drug-treated animals infected with XJ-44 all died. Replication of XJ-44, detectable only at low levels in unmanipulated guinea pigs, was almost as extensive as seen in Romero infections. Although virus first appeared in both groups by day 5, in general, viral antigen development, histopathological lesions, and mortality were all delayed in the drug-treated XJ-44-infected animals in comparison with Romero-infected animals. Although typical AHF developed in both the Romero-infected and immunosuppressed, XJ-44-infected guinea pigs, the Romero animals developed more fulminating disease with little or no brain involvement. In contrast, the XJ-44 group had an unrelenting progressive course, with many survivors past the acute phase of disease and into a late phase characterized by brain-associated virus and occasional rear-limb paralysis. Romero-infected guinea pigs showed few histological lesions in lymph nodes, spleen, and bone marrow on days 5 to 9 (despite virus replication at these sites as determined by PFU and IFA techniques). Severe lesions were observed in these organs from day 11 until death and were characterized by lymphoid necrosis and depletion of nodes and spleen as well as necrosis and degeneration of bone marrow. Such lesions eventually developed in CY-and C-A-immunosuppressed guinea pigs infected with XJ-44 Junin virus, but similar lesions found in C-A only control animals confounded the interpretation with this group.
Signs of nervous system dysfunction or brain lesions or evidence for viral replication in the brain were only seen 2 to 3 weeks postinfection or later. By this time, Romero-infected animals had died with typical viral hemorrhagic fever. They had detectable viral antigen in the brain but had no clinical signs or pathological changes in that organ. Immunosuppressed XJ-44-infected animals dying in the fourth week of infection often had relatively high brain virus titers, foci of encephalitis and gliosis, and hind-limb paralysis. This course of events may have different pathogenesis and determinants than more acute disease associated with viral replication in other viscera.
The pathophysiological changes leading to a fatal outcome and the mechanisms by which virus infection induces them remain speculative for all the arenavirus hemorrhagic fevers (22, 22a) . Nevertheless, the prominent lymphoid and bone marrow necrosis seen in these fatal Junin guinea pig infections is not immune mediated. Immunosuppression does not protect against disease induction by a virulent strain, and the adequacy of immunosuppression was vouchsafed by the results with an attenuated strain. The same treatment that failed to protect against the guinea pig-lethal Romero isolate resulted in a fatal outcome with the XJ-44 strain and with almost as rapid and severe a sequence of pathogenetic consequences. This raises two critical issues: (i) what is the mechanism of disease induction by these relatively non-cytocidal viruses, and (ii) how are nonfatal Junin-infections controlled? We have no data relevant to the first question (reviewed in reference 22a) but have measured the immune response relevant to the second. In the XJ-44-infected guinea pig, virus abruptly decreases in critical sites of replication in lymphoid tissues between days 7 and 10. We initially detected fluorescent antibodies at this time, but circulating serum-neutralizing antibodies, often a candidate for limiting viral spread in other systems, was not demonstrated for another week. Two mechanisms for lysing Junin virus-infected cells became operative during the critical 7-to 10-day time period: (i) cytolysis by antibody plus complement (Kenyon and Peters, manuscript in preparation), and (ii) cytolysis by spleen cells (Kenyon and Peters, submitted). Indeed, the second mechanism was shown to be antibodydependent cell-mediated cytotoxicity (no diminution of lysis after treatment of spleen cells with monoclonal antibody generated against guinea pig T-cells, blocked by aggregated human gamma globulin, still measureable at 30 days postinfection, response with B-cell-enriched fractions). Thus, all the measured immune responses seem to be antibody dependent, and the common denominator is anti-infected cell, not particularly antivirus. Since, however, the absolute sensitivity of assays in measuring the immune response and the exact antibody species are unknown, we cannot establish with certainty which is first operative, but there is no clear support for an overriding role for neutralizing antibody.
Immunosuppression with CY or C-A unleashes the potential of XJ-44 but delays or inhibits PRN and fluorescent antibodies as well as spleen cell cytotoxicity responses. The two drugs used can have profound effects on both T-and B-cell responses. It is probably relevant that no immune response is detected in the virulent virus infection and points to the importance of immunosuppression by Junin virus itself. Guinea pigs infected with virulent Junin strains appear to be immunosuppressed with respect to both viral and other antigens (1, 20) . This may not be surprising in light of the extent of macrophage infection and lymphoid pathology but may be relevant to life or death outcome.
These data from a model of lethal arenavirus hemorrhagic fever contrast with those classically obtained in mice inoculated intracranially with LCMV in two prominent ways: (i) the lack of immunopathology, and (ii) the predominance of evidence supporting B-cell products as the most important determinant of recovery. Our studies, as well as those of others, have well established the similarities of hemorrhagic fever infections in humans to those expressed by the guinea pig model (11, 12, 29) rather than to those expressed by the encephalitic mouse model (22a) . Although the argument that immunoglobulin is responsible for recovery is circumstantial, antibody in the form of convalescent plasma aborts AHF in both guinea pigs (30) and humans (14) . In part, these observations may reflect interspecies differences in eradicating cells with foreign surface antigens. The relative role of antibody in Old World arenavirus infections, such as Lassa fever and LCMV, also seems to be much less than in the South American hemorrhagic fevers (22) . Final resolution of these problems is a necessity for further advances in therapy and vaccine development for these viruses.
